Stocks and Investing
Stocks and Investing
Thu, January 4, 2024
[ Thu, Jan 04th 2024
] - WOPRAI
[ Thu, Jan 04th 2024
] - WOPRAI
[ Thu, Jan 04th 2024
] - WOPRAI
[ Thu, Jan 04th 2024
] - WOPRAI
[ Thu, Jan 04th 2024
] - WOPRAI
[ Thu, Jan 04th 2024
] - WOPRAI
[ Thu, Jan 04th 2024
] - WOPRAI
[ Thu, Jan 04th 2024
] - WOPRAI
[ Thu, Jan 04th 2024
] - WOPRAI
[ Thu, Jan 04th 2024
] - WOPRAI
[ Thu, Jan 04th 2024
] - WOPRAI
[ Thu, Jan 04th 2024
] - WOPRAI
[ Thu, Jan 04th 2024
] - WOPRAI
[ Thu, Jan 04th 2024
] - WOPRAI
[ Thu, Jan 04th 2024
] - WOPRAI
[ Thu, Jan 04th 2024
] - WOPRAI
[ Thu, Jan 04th 2024
] - WOPRAI
Wed, January 3, 2024
[ Wed, Jan 03rd 2024
] - WOPRAI
[ Wed, Jan 03rd 2024
] - WOPRAI
[ Wed, Jan 03rd 2024
] - WOPRAI
[ Wed, Jan 03rd 2024
] - WOPRAI
[ Wed, Jan 03rd 2024
] - WOPRAI
[ Wed, Jan 03rd 2024
] - WOPRAI
[ Wed, Jan 03rd 2024
] - WOPRAI
[ Wed, Jan 03rd 2024
] - WOPRAI
[ Wed, Jan 03rd 2024
] - WOPRAI
[ Wed, Jan 03rd 2024
] - WOPRAI
[ Wed, Jan 03rd 2024
] - WOPRAI
Michael Petusky Maintained (ANIK) at Buy with Increased Target to $29 on, Jan 3rd, 2024
Michael Petusky of Barrington Research, Maintained "Anika Therapeutics, Inc." (ANIK) at Buy with Increased Target from $28 to $29 on, Jan 3rd, 2024.
Michael, nor any peers, have made any analyst calls on ANIK in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources